The total return over the past 12 months is -44.11% vs. +16.94% for the S&P 500. So far it's up -22.52% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (44.11%) | (83.20%) | (79.14%) | N/A | N/A | N/A |
| Total Return CAGR | (44.11%) | (83.20%) | (79.14%) | N/A | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Alzamend Neuro Inc (ALZN)
| Year | Start price | End price | ALZN Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $1.82 | $1.41 | (22.52%) | +14.51% | (37.03%) |
| 2025 | $10.44 | $1.82 | (82.57%) | +17.72% | (100.29%) |
| 2024 | $80.10 | $10.44 | (86.97%) | +24.89% | (111.86%) |
| 2023 | $762.57 | $80.10 | (89.50%) | +26.19% | (115.69%) |
| 2022 | $2,565.00 | $762.57 | (70.27%) | (18.17%) | (52.10%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
